Search within:  

Sort results by:      



1-20 of 37   Next >
 
1.  
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer. 2014 Apr. NGC:010348
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer. 2013 Aug. NGC:010540
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy. 2015 Dec 16. NGC:010879
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. 2013 Jun. NGC:009787
Association for Molecular Pathology - Medical Specialty Society; College of American Pathologists - Medical Specialty Society; International Association for the Study of Lung Cancer - Disease Specific Society. View all guidelines by the developer(s)
5.  
Non-small cell lung cancer stage IV. 2011 Jun (revised 2013 Nov). NGC:010261
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
7.  
Management of lung cancer. A national clinical guideline. 1998 Feb (revised 2014 Feb). NGC:010220
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
10.  
ACR Appropriateness Criteria® induction and adjuvant therapy for N2 non–small-cell lung cancer. 1999 (revised 2013). NGC:010179
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
12.  
13.  
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. 1996 (revised 2012 Dec 18). NGC:009318
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
14.  
ACR Appropriateness Criteria® ovarian cancer screening. 1996 (revised 2012). NGC:009255
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
ACR Appropriateness Criteria® pulmonary hypertension. 2012. NGC:009668
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
16.  
Early detection of cancers. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009647
Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s)
17.  
18.  
ACR Appropriateness Criteria® thyroid carcinoma. 2013. NGC:010177
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. 2013 Aug. NGC:010032
American Association for the Study of Liver Diseases - Nonprofit Research Organization; American Society of Transplantation - Professional Association. View all guidelines by the developer(s)
1-20 of 37   Next >